Q4 2024 Earnings Call Transcript March 12, 2025 Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.15 ...

The gas chromatography market size was valued at $1.7 billion in 2021 and is projected to reach $3.2 billion by 2031, registering a CAGR of 6.1% by 2 ...

The global electrophoresis market size was $2.3 billion in 2021, and is projected to reach $4 billion by 2031, growing at a CAGR of 5.7% from 2022 to ...

DelveInsight recently conducted an in-depth MASH Market Size and Share Assessment to help a pharmaceutical client understand the evolving Metabolic Dysfunction-Associated Steatohepatitis (MASH) market ...

Major indices closed lower on Thursday as market participants digested yet another key inflation reading and new tariff ...

Major indices were in the red early on Thursday as market participants digested yet another key inflation reading and new ...

AbbVie Inc. stands out as one of the top pharma stocks to buy, according to hedge funds. The company exceeded analyst ...

Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...

Pete Stavropoulos; Analyst; Cantor Fitzgerald & Co. Good afternoon and welcome to Voyager Therapeutics fourth-quarter and year-end 2024 financial results conference call. (Operator Instructions) ...

Wells Fargo analyst Yanan Zhu lowered the firm’s price target on Voyager Therapeutics (VYGR) to $10 from $12 and keeps an Overweight rating on ...

Merck unveils a $1 billion vaccine manufacturing facility in Durham, North Carolina, expanding its U.S. production and ...

SpringWorks Therapeutics is working on new potential indications for its IP portfolio while running additional trials. See ...